Brookstone Capital Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $318K | Sell |
3,327
-80,671
| -96% | -$7.74M | ﹤0.01% | 1085 |
|
|
2026
Q1 | $8.7M | Sell |
83,998
-5,538
| -6% | -$628K | 0.1% | 229 |
|
|
2025
Q4 | $9.03M | Sell |
89,536
-4,796
| -5% | -$521K | 0.1% | 221 |
|
|
2025
Q3 | $11.6M | Buy |
94,332
+88,024
| +1,395% | +$10.9M | 0.14% | 186 |
|
|
2025
Q2 | $757K | Buy |
6,308
+381
| +6% | +$50.8K | 0.01% | 642 |
|
|
2025
Q1 | $873K | Buy |
5,927
+46
| +0.8% | +$7.02K | 0.01% | 588 |
|
|
2024
Q4 | $955K | Sell |
5,881
-29
| -0.5% | -$4.74K | 0.01% | 545 |
|
|
2024
Q3 | $963K | Sell |
5,910
-161
| -3% | -$23.9K | 0.01% | 527 |
|
|
2024
Q2 | $833K | Sell |
6,071
-1,413
| -19% | -$196K | 0.01% | 537 |
|
|
2024
Q1 | $1.15M | Sell |
7,484
-83,052
| -92% | -$12.4M | 0.02% | 458 |
|
|
2023
Q4 | $12.9M | Sell |
90,536
-4,438
| -5% | -$592K | 0.25% | 108 |
|
|
2023
Q3 | $11.8M | Sell |
94,974
-5,161
| -5% | -$784K | 0.26% | 111 |
|
|
2023
Q2 | $15.8M | Buy |
100,135
+164
| +0.2% | +$26.5K | 0.32% | 86 |
|
|
2023
Q1 | $15.8M | Buy |
99,971
+5,839
| +6% | +$876K | 0.31% | 91 |
|
|
2022
Q4 | $13.6M | Buy |
94,132
+17,845
| +23% | +$2.53M | 0.28% | 100 |
|
|
2022
Q3 | $9.85M | Buy |
76,287
+6,312
| +9% | +$911K | 0.23% | 116 |
|
|
2022
Q2 | $9.89M | Buy |
69,975
+21,428
| +44% | +$3.06M | 0.22% | 113 |
|
|
2022
Q1 | $7.17M | Buy |
48,547
+41,499
| +589% | +$6.36M | 0.14% | 148 |
|
|
2021
Q4 | $1.27M | Buy |
7,048
+314
| +5% | +$52.3K | 0.02% | 344 |
|
|
2021
Q3 | $1.08M | Sell |
6,734
-326
| -5% | -$56.1K | 0.02% | 372 |
|
|
2021
Q2 | $1.26M | Buy |
7,060
+3,306
| +88% | +$603K | 0.02% | 331 |
|
|
2021
Q1 | $724K | Sell |
3,754
-12
| -0.3% | -$2.31K | 0.03% | 293 |
|
|
2020
Q4 | $760K | Buy |
3,766
+102
| +3% | +$21.1K | 0.03% | 273 |
|
|
2020
Q3 | $770K | Sell |
3,664
-249
| -6% | -$55.5K | 0.04% | 224 |
|
|
2020
Q2 | $858K | Sell |
3,913
-878
| -18% | -$175K | 0.05% | 181 |
|
|
2020
Q1 | $830K | Buy |
4,791
+84
| +2% | +$13.9K | 0.05% | 176 |
|
|
2019
Q4 | $723K | Buy |
4,707
+92
| +2% | +$13.8K | 0.04% | 227 |
|
|
2019
Q3 | $701K | Buy |
4,615
+164
| +4% | +$25.9K | 0.04% | 223 |
|
|
2019
Q2 | $681K | Buy |
4,451
+538
| +14% | +$82.2K | 0.04% | 212 |
|
|
2019
Q1 | $628K | Buy |
3,913
+193
| +5% | +$29.9K | 0.04% | 179 |
|
|
2018
Q4 | $573K | Buy |
3,720
+347
| +10% | +$54.1K | 0.04% | 167 |
|
|
2018
Q3 | $507K | Buy |
+3,373
| New | +$479K | 0.04% | 271 |
|
|
2015
Q4 | – | Sell |
-897
| Closed | -$104K | – | 279 |
|
|
2015
Q3 | $104K | Sell |
897
-855
| -49% | -$96K | 0.02% | 264 |
|
|
2015
Q2 | $182K | Sell |
1,752
-138
| -7% | -$14.9K | 0.02% | 241 |
|
|
2015
Q1 | $209K | Sell |
1,890
-195
| -9% | -$21.2K | 0.03% | 177 |
|
|
2014
Q4 | $217K | Sell |
2,085
-15
| -0.7% | -$1.5K | 0.04% | 154 |
|
|
2014
Q3 | $202K | Buy |
+2,100
| New | +$190K | 0.04% | 157 |
|
Other funds holding CLX
CIM
BHIA
SIS
GHAM
CWA
CWP
GC
LOPW
YCM
Brookstone Capital Management's CLX Position: Q2 2026 in Review
Brookstone Capital Management reduced its Clorox (CLX) stake by 96% in Q2 2026, selling an estimated $7.74M and leaving 3,327 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.
Brookstone Capital Management first reported a position in CLX in Q3 2014 and has held it in 37 quarters since. The position peaked at $15.8M in Q2 2023. 202 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Brookstone Capital Management held 3,327 shares of Clorox worth $318K as of Q2 2026.
- Brookstone Capital Management sold 80,671 Clorox shares in Q2 2026, an estimated $7.74M.
- Clorox made up ﹤0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #1085 holding.
- Brookstone Capital Management first reported a position in Clorox in Q3 2014 and has held it in 37 quarters since.
- Brookstone Capital Management's Clorox position peaked at $15.8M in Q2 2023.
- 202 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.